TROPION-Lung07: Phase III study of Dato-DXd + pembrolizumab ± platinum-based chemotherapy as 1L therapy for advanced non-small-cell lung cancerIsamu Okamoto, Aaron Lisberg, Shoichi Kuyama et al.|Future Oncology|2024Cited by 20
185O Trastuzumab deruxtecan (T-DXd) vs treatment of physician’s choice (TPC) in patients (pts) with HER2-low unresectable and/or metastatic breast cancer (mBC): A detailed safety analysis of the randomized, phase III DESTINY-Breast04 trialH. S. Rugo, Shanu Modi, Fátima Cardoso et al.|ESMO Open|2023Cited by 11